GeoVax Labs Quarterly Income Statements Chart
Quarterly
|
Annual
GeoVax Labs Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2015-12-31 | 2014-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-06-27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue from government contract | 300,677 | ||||||||||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||||||
| research and development | 4,276,868 | 4,425,728 | 6,233,870 | 6,947,979 | 4,719,728 | 2,819,189 | 3,764,562 | 2,721,196 | 1,307,177 | 1,330,544 | 12,894,191 | 1,224,362 | 832,835 | 602,783 | 757,346 | 416,756 | 461,421 | 808,936 | 436,096 | 467,674 | 451,227 | 555,718 | 461,760 | 557,696 | 372,202 | 486,994 | |||||||||
| general and administrative | 1,086,030 | 1,457,353 | 1,459,880 | 1,651,775 | 1,459,093 | 1,451,425 | 1,622,939 | 1,249,337 | 935,311 | 1,179,024 | 1,014,512 | 757,432 | 733,499 | 1,071,710 | 831,364 | 435,013 | 427,292 | 502,345 | 423,485 | 291,475 | 412,650 | 510,064 | 471,869 | 458,974 | 359,197 | 357,228 | |||||||||
| total operating expenses | 5,362,898 | 5,883,081 | 7,693,750 | 8,599,754 | 6,178,821 | 4,270,614 | 5,387,501 | 3,970,533 | 2,242,488 | 2,509,568 | 13,908,703 | 1,981,794 | 1,566,334 | 1,674,493 | 1,588,710 | 851,769 | 888,713 | 1,311,281 | 859,581 | 759,149 | 863,877 | 1,065,782 | 933,629 | 1,016,670 | 731,399 | 844,222 | |||||||||
| income from operations | -5,062,221 | -5,883,081 | -7,693,750 | -8,599,754 | -6,178,821 | -4,270,614 | -5,387,501 | -3,970,533 | -2,242,488 | -2,428,042 | -13,743,741 | -1,951,380 | -1,486,626 | -1,564,076 | -1,337,089 | -436,311 | -448,111 | -595,304 | -591,067 | -425,940 | -653,936 | -701,550 | -634,334 | -667,326 | -638,134 | -622,923 | |||||||||
| yoy | -18.07% | 37.76% | 42.81% | 116.59% | 175.53% | 75.89% | -60.80% | 103.47% | 50.84% | 55.24% | 927.89% | 347.25% | 231.75% | 162.74% | 126.22% | 2.43% | -31.47% | -15.14% | -6.82% | -36.17% | 2.48% | 12.62% | |||||||||||||
| qoq | -13.95% | -23.53% | -10.54% | 39.18% | 44.68% | -20.73% | 35.69% | 77.06% | -7.64% | -82.33% | 604.31% | 31.26% | -4.95% | 16.98% | 206.45% | -2.63% | -24.73% | 0.72% | 38.77% | -34.87% | -6.79% | 10.60% | -4.94% | 4.57% | 2.44% | ||||||||||
| operating margin % | |||||||||||||||||||||||||||||||||||
| other income: | |||||||||||||||||||||||||||||||||||
| interest income | 5,471 | 32,949 | 101,342 | 190,936 | 251,201 | 232,698 | 3,692 | 2,431 | 789 | 527 | 738 | 877 | 1,068 | 2,053 | 1,369 | 90 | 60 | 752 | 1,694 | 2,560 | 881 | 1,224 | 1,121 | 1,058 | 1,716 | 1,318 | |||||||||
| interest expense | -7,292 | -531 | -755 | -802 | -134,427 | -7,153 | -1,142 | -1,220 | -1,054 | -1,093 | -1,128 | -1,132 | -625 | -625 | -208 | ||||||||||||||||||||
| total other income | -1,821 | 3,692 | 2,431 | 789 | 527 | 738 | 877 | 172,593 | 1,298 | 567 | -134,337 | -7,093 | -390 | 474 | 1,506 | -212 | 96 | -11 | 433 | 1,091 | 1,110 | ||||||||||||||
| net income | -5,064,042 | -5,850,132 | -7,592,408 | -8,408,818 | -5,927,620 | -4,037,916 | -5,383,809 | -3,968,102 | -2,241,699 | -2,427,515 | -13,743,003 | -1,950,503 | -1,314,033 | -1,562,778 | -1,336,522 | -570,648 | -455,204 | -595,694 | -590,593 | -424,434 | -654,148 | -701,454 | -634,345 | -666,893 | -637,043 | -621,813 | |||||||||
| yoy | -14.57% | 44.88% | 41.02% | 111.91% | 164.43% | 66.34% | -60.83% | 103.44% | 70.60% | 55.33% | 928.27% | 241.80% | 188.67% | 162.35% | 126.30% | 34.45% | -30.41% | -15.08% | -6.90% | -36.36% | 2.69% | 12.81% | |||||||||||||
| qoq | -13.44% | -22.95% | -9.71% | 41.86% | 46.80% | -25.00% | 35.68% | 77.01% | -7.65% | -82.34% | 604.59% | 48.44% | -15.92% | 16.93% | 134.21% | 25.36% | -23.58% | 0.86% | 39.15% | -35.12% | -6.74% | 10.58% | -4.88% | 4.69% | 2.45% | ||||||||||
| net income margin % | |||||||||||||||||||||||||||||||||||
| basic and diluted: | |||||||||||||||||||||||||||||||||||
| net income per common share | -1.99 | -2.47 | -13.6 | -0.32 | -0.22 | -0.15 | -0.2 | -0.17 | -0.18 | -0.34 | -2.24 | -0.31 | -0.21 | -0.29 | -0.713 | -0.73 | -0.03 | -0.13 | -1.43 | -0.01 | |||||||||||||||
| weighted-average shares outstanding | 2,539,878 | 2,367,050 | 1,817,282 | 26,544,058 | 26,443,649 | 26,338,576 | 16,973,194 | 23,461,665 | 12,721,696 | 7,109,473 | 6,099,933 | 6,349,297 | 6,322,799 | 5,332,058 | 1,383,829 | 782,978 | 13,823,452 | 4,687,893 | 60,402 | 491,707 | 163,584,755 | 124,170,143 | |||||||||||||
| grant revenue | |||||||||||||||||||||||||||||||||||
| grant and collaboration revenue | 20,381.5 | 164,962 | 30,414 | 79,708 | 251,621 | 415,458 | 440,602 | 268,514 | 333,209 | 209,941 | 299,295 | 349,344 | 93,265 | ||||||||||||||||||||||
| gain on debt extinguishment | 172,056 | ||||||||||||||||||||||||||||||||||
| grant revenues | 81,526 | ||||||||||||||||||||||||||||||||||
| grant and collaboration revenues | 110,417 | 715,977 | 364,232 | 221,299 | |||||||||||||||||||||||||||||||
| loss per common share | -38.88 | -0.03 | -1.01 | -0.01 | 0 | 0 | |||||||||||||||||||||||||||||
| weighted-averages shares outstanding | 13,038,871 | 649,486 | 167,407,100 | 155,209,337 |
We provide you with 20 years income statements for GeoVax Labs stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GeoVax Labs stock. Explore the full financial landscape of GeoVax Labs stock with our expertly curated income statements.
The information provided in this report about GeoVax Labs stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.